• Issue

    Clinical & Experimental Allergy: Volume 55, Issue 7

    515-595
    July 2025

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 515-517
  • First Published: 02 July 2025

ORIGINAL ARTICLE

Free Access

Risk Factors for Fatal and Near-Fatal Food Anaphylaxis: Analysis of the Allergy-Vigilance Network Database

  • Pages: 532-540
  • First Published: 29 May 2025
Risk Factors for Fatal and Near-Fatal Food Anaphylaxis: Analysis of the Allergy-Vigilance Network Database

  • Of the 2621 food anaphylaxis cases, 731 (27.9%) were considered as severe (grade 3, [94%] and grade 4 [6%]; 19 deaths).
  • There were more grade 4 anaphylaxis cases in children than in adults (p = 0.01).
  • In the multivariate analysis, individuals with a grade 4 anaphylaxis were more likely to have a history of asthma (OR [95% CI]: 5.46 [2.02–14.73], p < 0.001), peanut and cow's milk as culprit food triggers (OR: 4.94 [1.50–16.23], p = 0.009; OR: 6.44 [1.20–34.56], p = 0.03; respectively), compared to individuals with grade 3 anaphylaxis.

Free Access

Identification of the Top 15 Drugs Associated With Anaphylaxis: A Pharmacovigilance Study

  • Pages: 541-551
  • First Published: 08 June 2025
Identification of the Top 15 Drugs Associated With Anaphylaxis: A Pharmacovigilance Study

This pharmacovigilance study identified the 15 most-reported drugs linked to anaphylaxis, including antibiotics and NSAIDs. The majority of drug-associated anaphylaxis reports were reported to occur within 2.5 h for most drugs. Despite being life-threatening yet recoverable, delayed recognition highlights the need for improved guidelines and enhanced pharmacovigilance systems for better management.

RESEARCH LETTER

CORRECTION

Free Access

Correction to “Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study”

  • Page: 593
  • First Published: 24 March 2025